In the core binding factor (CBF)b-smooth muscle myosin heavy chain (SMMHC) acute myeloid leukemia (AML) oncoprotein, CBFb lies N-terminal to the a-helical rod domain of SMMHC. Deletion of the SMMHC assembly competence domain (ACD), conserved among skeletal, smooth and nonmuscle myosins, prevents multimerization, inhibition of CBF and inhibition of cell proliferation. To define the amino acids critical for ACD function, three outer surface residues of ACD helices A-D, the subsequent helices E-H or the more N-terminal X or Z helices were now mutated. Variants were assessed for multimerization in low ionic strength in vitro and for nuclear localization as a measure of in vivo multimerization. Mutation of individual helices C-H reduced multimerization, with alteration of the outer surface of helices D or E having the greatest effect. The ability of these SMMHC variants to slow murine myeloid progenitor proliferation largely paralleled their effects on multimerization. Divergence at the boundaries of the ACD may reflect quantitative differences between in vitro and in vivo filament assembly. Each helix mutant retained the ability to bind the mSin3A corepressor. Agents interacting with the outer surface of the CBFb-SMMHC ACD that prevent multimerization may be effective as novel therapeutics in AML.
Introduction
Core binding factor (CBF) is a family of heterodimeric transcription factors containing a CBFa subunit, RUNX1/acute myeloid leukemia (AML) 1, RUNX2/ AML3 or RUNX3/AML2, and a CBFb subunit (reviewed by Friedman, 1999) . CBFb alone does not bind DNA but interacts with the Runt domain of CBFa subunits and increases their DNA affinity. AML1 localizes to the nucleus, whereas the large majority of CBFb is in the cytoplasm, reflecting expression in excess of AML1 and its affinity for the actin cytoskeleton (Yoshida et al., 2005) . Of the three CBFa subunits, AML1 is most critical for hematopoiesis, as mice lacking AML1 do not develop definitive hematopoietic cells. CBFb (À/À) mice have a similar phenotype, reflecting the importance of the AML1:CBFb interaction.
CBFb-smooth muscle myosin heavy chain (SMMHC) (Figure 1a ) is expressed from the inv(16) or t(16;16) chromosomes in 8% of AMLs and contains the majority of CBFb linked to the a-helical rod domain of SMMHC (Liu et al., 1993) . The CBFb domain retains the ability to interact with AML1. Mice expressing CBFb-SMMHC are phenotypically similar to AML1 (À/À) or CBFb (À/À) mice (Castilla et al., 1996; Okuda et al., 1996; Wang et al., 1996a, b) . CBFb-SMMHC cooperates with ethylnitrosourea mutagenesis, mutation of the p16p19 cell cycle regulatory locus or coexpression of the PLAG1 or PLAGL2 transcription factors, to induce AML in mice (Castilla et al., 1999; Yang et al., 2002; Landrette et al., 2005; Moreno-Miralles et al., 2005) .
The a-helical SMMHC rod domain dimerizes as a coiled-coil structure (Figure 1b ). The internal a and d residues are often hydrophobic. The e and g residues stabilize the dimer by forming salt bridges, and the outer surface bcf residues are available to mediate multimerization. The dimer assembles into a staggered parallel array following antiparallel nucleation (Figure 1c) , dependent upon the integrity of the 29-residue C-terminal assembly competence domain (ACD; Sohn et al., 1997) . The ACD is conserved among vertebrate skeletal, smooth and nonmuscle myosins. Deletion of the ACD, designated as a-helices A-D (Figure 1a and d) , prevents CBFb-SMMHC multimerization, nuclear localization and inhibition of myeloid cell proliferation (Kummalue et al., 2002; D'Costa et al., 2005) . The standard assay for in vitro myosin multimerization takes advantage of the propensity of its rod domain to assemble into filaments in low ionic strength solutions. To explain the effect of ACD deletion on in vivo localization, we hypothesize that a small amount of CBFb-SMMHC is held in the nucleus by virtue of its interaction with CBFa subunits and that additional fusion protein can only remain nuclear if it multimerizes in vivo with the bound fraction.
The four ACD a-helices are part of a conserved 63-residue region more neutral than surrounding acidic regions (Cohen and Parry, 1998) . This hypothetical extended ACD consists of helices Z-H (Figure 1a and d) and extends to the nonhelical C-terminal tail. We have now carried out a mutagenic analysis of the extended ACD in CBFb-SMMHC to experimentally identify the residues required for multimerization. To avoid disrupting the local coiled-coil structure, we focused on mutating bcf residues. Clusters of bcf residues in helices X, Z, A-H, or in combinations of these were mutated from charged residues to threonine, serine or alanine (Figure 1d ). In vitro multimerization was not affected by mutation of helices X, Z, A or B, placing an N-terminal boundary on the region contributing the majority of ACD activity. Helices C-H each contributed to in vitro multimerization, but mutation of helices D or E had the greatest effect. Mutant DE had greater solubility in 0.1 M KCl and reduced nuclear localization, reflecting reduced in vivo multimerization, compared with BC, CD, EF, FG or GH.
CBFb-SMMHC inhibits G1 to S cell cycle progression of hematopoietic cell lines or murine myeloid progenitors dependent upon residues in the CBFb domain that contact AML1 (Cao et al., 1997 (Cao et al., , 1998 D'Costa et al., 2005) . AML1-ETO also slows proliferation (Burel et al., 2001) , and exogenous AML1 accelerates G1 dependent upon its transactivation domain (Strom et al., 2000; Bernardin and Friedman, 2002) . Induction of cdk4 and cyclin D3 may account for stimulation of proliferation by AML1 (Lou et al., 2000; Bernardin-Fried et al., 2004) . Therefore, inhibition of cell proliferation by CBFb-SMMHC or its variants serves as an assay for inhibition of endogenous AML1. Inhibition of murine myeloid progenitor proliferation by the ACD helix mutants largely paralleled their in vitro multimerization activities, but differences in the pattern of these activities raises the possibility that direct interaction of the ACD with a heterologous protein also plays a role in cell cycle inhibition. Deletion of the core ACD prevented interaction with the mSin3A corepressor (Durst et al., 2003) . However, each of the single-helix mutants coimmunoprecipitated mSin3A, suggesting this is not the critical interacting factor. The significance of our findings for the mechanism of leukemogenesis by CBFb-SMMHC, for developing novel therapeutics targeting its ACD, and for myosin assembly in general will be discussed. CBFb-SMMHC is designated INV for brevity at times in the following sections.
Results
The outer surfaces of ACD helices C-H, especially D and E, are required for multimerization Ba/F3 lines were derived expressing INV variants carrying mutations in single helices, X, Z, A, B, C, D, E, F, G or H, or combinations of helices, BC, CD, DE, EF, FG, GH or BCD. We have used Ba/F3 pro-Blymphoid cells for several prior studies on cell cycle regulation by INV, as these cells are growth factor dependent and because the zinc-responsive metallothionein (MT) promoter is less leaky in them compared with 32Dcl3 myeloid cells. Multiple subclones were isolated for each variant, and those expressing the ACD mutants at a level similar to that of INV in Ba/F3-INV cells were identified. To assess multimerization in vitro, cell extracts were prepared in the presence of 0.3 M KCl, which prevents assembly of myosins into filaments, although the hydrophobic and salt bridge interactions mediating dimerization are not affected. The INV An a-helical wheel analysis illustrating formation of a coiled-coil dimer. The a and d residues form interacting hydrophobic surfaces, and the e and g residues stablilize the dimer by forming salt bridges. The bcf residues on the outer surfaces are available for multimerization. (c) Diagram of myosin filament assembly, wherein the ACD (black) contacts more N-terminal surfaces of the rod domain. The central two rods represent antiparallel nucleation, which is followed by parallel, staggered assembly. (d) The ACD and surrounding residues. Underlined fbc residues in helices X, Z or A-H were mutated in this study (see Materials and methods).
Critical ACD Surface in CBFb-SMMHC L Zhang et al proteins were partially purified by isolating proteins soluble at 1001C, a standard approach for purifying proteins with coiled-coil domains as they resist heat denaturation. We then endeavored to equalize the amount of each variant subjected to the multimerization assay, based on prior Western analysis of whole-cell lysates. Western analysis of one set of such extracts demonstrates that the mutants were expressed at similar levels, with most nearly identical to INV and a range of 1-to 2-fold, based on image scanning (Figure 2a) . None of the input expression levels were routinely lower or higher than the rest; for example, mutant G, although the lowest in this set of samples, was 1.5-fold higher than mutant B in an independently analysed extract of each (not shown). The extracts were split evenly, dialysed against 0.05, 0.1 or 0.2 M KCl, and centrifuged at 14 000 g for 1 h. An example of Western analysis of these fractions is shown (Figure 2b ). At 0.2 M KCl, INV or mutant D was almost entirely present in the supernatant, and at 0.05 M KCl, the large majority of each multimerized and was detected in the pellet. At 0.1 M KCl, more than half of INV was in the pellet whereas more than two-thirds of mutant D remained in the supernatant. The behavior of mutant D was similar even when a fivefold increased amount was subjected to dialysis and fractionation ( Figure 2b , bottom panel), indicating that this assay is not sensitive to small variations in protein concentration. INV and its variants were subjected to three independent multimerization assays, and the percentage of each in the supernatant fraction in 0.l M KCl is shown ( Figure 2c ). The DACD variant lacks 28 residues corresponding to helices A-D and did not multimerize, as observed previously (Kummalue et al., 2002) . Mutation of three residues on the outer surface of helices X, Z, A or B had no effect on solubility in 0.1 M KCl, when compared with INV. In contrast, mutation of the outer surface of helices C, D, E, F, G or H significantly reduced multimerization, with mutation of helices D or E having the greatest effect. Several variants harboring mutations of the bcf residues on the outer surface of adjacent helices were also compared. Consistent with the pattern observed with the single-helix mutants, CD multimerized less effectively than BC, and DE was significantly more soluble than BC, CD or EF ( Figure 2c ). Multimerization of DE was not significantly different than that of mutants D or E alone. Multimerization of CD was similar to C but unexpectedly greater than D alone in the three assays performed. Overall, this biochemical analysis suggests that helix C is the N-terminal boundary of the functional ACD, that helices C-H each participate in the initiation of filament assembly, and that the six outer surface resides of helices D and E make the greatest contribution. Deletion of helices A-D markedly impairs INV nuclear localization in Ba/F3 cells (Kummalue et al., 2002) . Although the biochemical basis for this is uncertain, the role these helices play in initiating Critical ACD Surface in CBFb-SMMHC L Zhang et al multimerization is consistent with the idea that once INV interacts with all the available nuclear AML1, the remainder is only retained in the nucleus by multimerization via the SMMHC domain. Therefore, we analysed the nuclear versus cytoplasmic distribution of INV and several of its variants. Nuclei were collected at 325 g for 10 min in 50 mM KCl. These centrifugation conditions did not pellet INV after dialysis into the same KCl concentration (not shown). Single-helix ACD mutations did not alter the cellular localization of INV (not shown). However, the DE variant consistently demonstrated a higher percentage of cytoplasmic expression compared with INV, BC, CD, EF, FG, GH or BCD, although not as great as deletion of the 28-residue ACD (Figure 3 ). This finding is consistent with the conclusion derived from the in vitro multimerization assay that the outer surface of helices D and E are the most critical for ACD activity. The G1/S ratio in the presence of zinc divided by the G1/S ratio in its absence is shown (mean and s.e. from two determinations).
Critical ACD Surface in CBFb-SMMHC L Zhang et al Ba/F3 cell lines expressing INV or its variants from the MT promoter were assessed for their transition from the G1 to S cell cycle phases in the absence or presence of zinc (Figure 4b ). An increased G1/S ratio in the presence of zinc reflects inhibition of cell cycle progression. INV dramatically slowed G1 progression, whereas its DACD variant was ineffective. Mutants X or Z retained the ability to markedly inhibit the G1 to S transition, consistent with their lack of contribution to multimerization. On the other hand, mutation of the outer surface of helices A, B, C, D, E, F, G or H each prevented INV from blocking Ba/F3 proliferation.
Mutation of the outer surface of ACD helices A-H does not prevent interaction with mSin3A INV binds the mSin3A corepressor dependent upon the integrity of the ACD (Durst et al., 2003) . Cos7 cells were transfected with GAL-INV(449-577) or derivatives carrying mutations in helices A-H on the outer surface of the ACD. GAL-INV(309-577DACD) was utilized to confirm the effect of deleting the ACD. The latter construct includes 140 additional N-terminal residues to avoid concern that deleting the ACD prevents multimerization by making the remaining helical region too short. Cell extracts were subjected to immunoprecipitation (IP) of endogenous mSin3A, and co-IP of exogenous GAL-INV proteins was analysed ( Figure 5 ). Compared with the immunoglobulin (Ig) or mSin3A peptide (P) controls, mSin3A antibody (Ab) coimmunoprecipitated GAL-INV and each of its point mutant derivatives but not GAL-INV(DACD). This assay is not sufficiently quantitative to allow conclusions regarding the relative affinities of different mutants. Nevertheless, although interaction with mSin3A requires integrity of the ACD, its interaction with individual ACD helices does not correlate with the effect of their mutation on inhibition of proliferation.
Discussion
CBFb-SMMHC is expressed as a consequence of chromosomal inversion in a subset of AML patients and contributes to leukemogenesis in murine models, suggesting that it is a valid target for novel therapeutics. Its CBFb segment interacts with AML1, but agents disrupting this interaction may be unduly toxic to hematopoietic stem cells whose development and maturation depend upon the AML1:CBFb heterodimer. We previously demonstrated that CBFb-SMMHC requires its C-terminal ACD for efficient multimerization and inhibition of CBF-mediated proliferation and have now sought to localize the ACD residues required for these activities. Deletion of the ACD obviates transformation by CBFb-SMMHC in a murine model (Kim et al., submitted), further suggesting that the ACD is valid target for novel therapeutics.
The biochemical interactions mediating myosin assembly into filaments are poorly understood. Assembly is initiated by anti-parallel interaction of rod domains followed by parallel assembly at each end to form a bipolar filament. Staggered multimerization is enforced by alternating zones of positive and negative charges on the outer surface of bcf residues (Hoppe and Waterston, 1996) . Deletion of 92 residues from the C-terminus of a rabbit myosin greatly increases its solubility at low ionic strength, whereas N-terminal deletions have no effect (Atkinson and Stewart, 1991) . Residues critical for myosin assembly were further localized to a 29-residue ACD near the C-terminus of skeletal muscle myosin; in particular, deletion of helices E-H did not prevent filament assembly, but further deletion of helices A-D did (Sohn et al., 1997) . Similarly, deletion of helices E-H in nonmuscle myosin II weakens multimerization, and deletion of its ACD has an even greater effect (Nakasawa et al., 2005) . A theoretical analysis demonstrates that helices A-D combined with 11 N-terminal and 23 C-terminal residues forms a 63-residue extended ACD, which has a more neutral overall charge than most other 63 residue myosin or paramyosin segments (Cohen and Parry, 1998) . The neutral charge characteristics of the ACD may allow it to recognize a similar, more proximal interaction surface during filament assembly. On the other hand, deletion of a negatively charged 28-residue region in nonmuscle myosin II, located 146 residues N-terminal to the ACD, prevents multimerization (Nakasawa et al., 2005) . Additional effort is necessary to fully identify the proximal ACDinteracting domain within the myosin rod.
To further define the residue critical for the activity of this important, evolutionarily conserved myosin functional domain, the outer surfaces of the nine helices that make up the postulated C-terminal CBFb-SMMHC extended ACD, helices Z and A-H, as well as the Figure 5 Effect of ACD mutations on interaction with mSin3A. Cos7 cells were transfected with CMV vectors expressing GAL-INV or the indicated ACD helix variants. Cell extracts prepared using 150 mM NaCl, 0.5% Triton X-100, 20 mM Tris, pH 7.5 and protease inhibitors were subjected to IP with mSin3A Ab or with rabbit IgG (Ig). IP was also carried out with Ab in the presence of blocking peptide (P). These three samples along with an input sample (I), corresponding to 2% of the protein used for each IP, were subjected to Western blotting (WB) using GAL4 antiserum.
Critical ACD Surface in CBFb-SMMHC L Zhang et al adjacent helix X, were mutated. Alteration of helices C-H, but not X, Z, A or B, reduced in vitro multimerization, with mutants D or E being the most soluble in 0.1 M KCl. The double-mutant DE was more soluble than CD, EF, FG or GH, again emphasizing the significance of the DE outer surface for filament assembly. Consistent with the importance of the DE helices, the DE variant demonstrated greater cytoplasmic expression than BC, CD, EF, FG, GH or even BCD, likely reflecting its reduced ability to multimerize, now manifest in vivo. The nuclear versus cytoplasm expression assay is apparently an insensitive measure of multimerization, as all the double-helix mutants except DE and the single-helix mutants were largely nuclear. Of note, CBFb-SMMHC is found in the nucleus of primary human leukemias (Liu et al., 1996) , although its cellular distribution in Ba/F3 cells may be influenced by supraphysiologic expression. Together, our findings indicate that helices X, Z, A and B play a minor role in multimerization compared to helices C-H and that helices D and E are the most critical. These findings extend the initial studies characterizing the ACD by uncovering the importance of helices C-terminal to the A-D region, especially helix E, by demonstrating the reduced importance of helices A, B and Z, and by showing that mutation of bcf residues on key helices is sufficient to reduce multimerization.
The question remains whether nucleation of CBFb-SMMHC multimerization accounts fully for the contribution of the ACD to leukemic transformation. As a first step towards addressing this question, we also assessed the ability of the ACD variants to inhibit progenitor or Ba/F3 proliferation, reflecting modulation of endogenous AML1 activities, and to bind mSin3A, which had been reported to help mediate repression of AML1-target genes. Of note, we previously demonstrated that murine marrow cells transduced with pBabePuro-CBFb-SMMHC express the transgene at levels similar to ME-1 cells, derived from a patient with inv(16)-associated AML (D'Costa et al., 2005) . The pattern of effects of the helix mutations on normal myeloid cell proliferation was qualitatively similar to their effects on multimerization. However, mutant B multimerized normally but had an intermediate effect on proliferation. Being at the edge of the experimentally defined ACD, mutation of helix B may only subtly affect multimerization, below the sensitivity of the in vitro assay employed. Mutation of helix H reduced multimerization, but had only a mild effect on progenitor proliferation. This finding raises the possibility that CBFb-SMMHC reduces proliferation independent of multimerization, via interaction of a heterologous protein with helices B-G.
In contrast to results with normal progenitors, mutation of helices A or B markedly reduced inhibition of Ba/F3 proliferation. Ba/F3 cells proliferate twice as rapidly as marrow cells and so may be more sensitive to subtle effects not detected by the in vitro multimerization assay. mSin3A interaction was retained by each of the helix point mutants, indicating that interaction with mSin3A
is not required for CBFb-SMMHC to inhibit endogenous AML1. Additional studies will be required to identify proteins interacting with the outer surface of the ACD and to determine their relevance to inhibition of AML1 by CBFb-SMMHC. It is worth noting, however, that SMMHC is a cytoplasmic protein that likely did not evolve to interact with transcriptional regulators. If one takes the perspective that initiating myosin multimerization is the key ACD function, then our findings indicate that agents reducing CBFb-SMMHC multimerization via interaction with the outer surface of helices D and E may contribute to the therapy of patients with AML associated with inv(16) or t(16;16). Identification of this critical ACD subdomain should assist studies aimed at locating the more N-terminal ACD interaction surface within SMMHC, which in turn will provide deeper understanding of myosin assembly and the means to design or screen for drugs targeting CBFb-SMMHC.
Materials and methods
Cell culture, transfection and cell cycle analysis Ba/F3 cells were cultured in Rosewell's Park Memorial Institute media 1640 with 10% heat-inactivated fetal bovine serum (HI-FBS) and 1 ng/ml interleukin-3 (IL-3, Peprotech, Rocky Hill, NJ, USA). 293 T and Cos7 cells were cultured in Dulbecco's modified Eagle's medium with 10% HI-FBS. All cultures contained penicillin-streptomycin. pMTCB6 plasmids, expressing INV and its derivatives from the MT promoter, were linearized with ScaI and 15 mg was electroporated into 5 Â 10 6 Ba/F3 cells in ice-cold phosphate-buffered saline (PBS) at settings of 270 mV and 950 mF. Stable transfectants were selected by limiting dilution in 96-well dishes in the presence of 1.2 mg/ml G418 (total). Zinc chloride was employed at 100 mM, and cell cycle analysis was carried out as described by pulsing for 30 min with bromodeoxyuracil (BrdU) followed by fixation and fluorescein isothiocyanateanti-BrdU and propidium iodide staining as described (Cao et al., 1997) .
Marrow cell transduction pBabePuro and its derivatives were packaged by transient transfection into 293 T cells at a ratio of 8 mg pBabePuro to 2 mg pEcokat (Finer et al., 1994) per 100 mm dish, using 20 ml Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Supernatant was collected 2 and 3 days after transfection, pooled and passed through a 0.45-mm filter. Transduction of murine myeloid progenitors was as described (D'Costa et al., 2005) . In brief, marrow was harvested from C57BL/6 mice injected intraperitoneally 5-6 days earlier with 150 mg/kg 5-fluorouracil. Red blood cells were lysed with NH 4 Cl, and the cells were then washed with PBS and cultured in Iscove's modified Dulbecco's medium (IMDM) with 10% HI-FBS, 10 ng/ml IL-3, 10 mg/ml IL-6 and 50 ng/ml stem cell factor (SCF, Peprotech) for 1 day. Viral supernatant was then added with 4 mg/ml polybrene for 2 additional days, followed by addition of 2 mg/ml puromycin. After 2 days, dead cells were removed by centrifugation through Lympholyte-M polysucrose (Cedarlane Labs, Ontario, Canada). Cells were then washed and cultured in IMDM with HI-FBS, IL-3, IL-6 and SCF, and viable counts were enumerated daily.
Plasmid construction
To introduce clustered mutations into INV, an 850 bp BglII/ XbaI fragment was transferred to pBluescript (Stratagene, La Jolla, CA, USA) and subjected to polymerase chain reaction mutagenesis using two flanking and two overlapping, mutagenic oligonucleotides. All mutations were confirmed by DNA sequencing and then transferred back into the INV cDNA in the context of pMTCB6. Clustered fbc residues in the individual helices shown in Figure 1d were changed as follows: X (LED to AAS), Z (EEK to AAS), A (AKQ to STS), B (REE to AAS), C (EQR to ATS), D (ARK to SAS), E (RDE to ATS), F (EEA to AAS), G (RNA to ATS) and H (SRG to AAG). Mutation of more than one helix was performed either iteratively or in one step. Several mutant INV cDNAs were subsequently transferred to the pBabePuro vector (Morgenstern and Land, 1990) . In addition, C-terminal residues 449-577 of several variants or INV, or residues 309-557 of INVDACD, were ligated downstream of the GAL4 DNAbinding domain in the pCMV5 vector (Durst et al., 2003) .
Cell nucleus and cytoplasm isolation and Western blotting
Ba/F3 cells were fractionated into nuclear and cytoplasmic fractions using a lysis buffer containing 50 mM KCl, 10 mM HEPES, pH 6.5, 2 mM MgCl 2 , 0.1% NP-40, 0.5 mM dithiothreitol (DTT) and protease inhibitors as described (Kummalue et al., 2002) . Nuclei were collected by microfuge centrifugation at 2000 r.p.m., 325 g, for 10 min. Cytoplasmic proteins were concentrated by precipitation using four volumes of acetone at À201C. Nuclear and cytoplasmic extract corresponding to equivalent numbers of cells were subjected to Western blotting using rabbit anti-CBFb antiserum as described (Cao et al., 1997) . Band intensities were quantified using NIH ImageJ 1.33 software.
In vitro multimerization assay To partially purify INV and its variants, Ba/F3 cells were lysed using 300 mM KCl, 0.1% NP-40, 10 mM HEPES, pH 6.5, 2 mM MgCl 2 and peptide protease inhibitors. The extracts were heated to 1001C for 15 min and clarified at 16 000 g for 5 min. Supernatants were dialysed overnight at 41C against 50, 100 or 200 mM KCl, 10 mM HEPES, pH 6.5, 2 mM MgCl 2 , 0.4 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM benzamidine and 0.5 mM spermidine. The dialysates were centrifuged in a microfuge at 14 000 g for 60 min at room temperature. Pellets were resuspended by incubating them with 600 mM KCl, 10 mM HEPES, pH 7.5, 0.5 mM DTT overnight. Supernatant and pellet samples corresponding to equivalent numbers of cells were subjected to Western blotting using CBFb antiserum. Statistical comparison of groups in this and other assays was carried out using Student's t-test.
Coimmunoprecipitation
Cos7 cells were transfected with GAL-INV fusion proteins using 16 ml Lipofectamine 2000 and 5 mg DNA per 100 mM dish. After 2 days, cells were collected by scraping, washed twice with 150 mM NaCl, 20 mM Tris, pH 7.5 and lysed for 20 min at 41C using 1000 ml 150 mM NaCl, 0.5% Triton X-100, 20 mM Tris, pH 7.5, 1 mM PMSF, 10 mg/ml leupeptin, 1 mg/ml peptstatin A, 1 mg/ml antipain, 1 mg/ml chymostatin, 2 mg/ml soybean trypsin inhibitor and 10 mg/ml aprotinin. After brief sonication, the extracts were spun at 16 000 g in a microfuge for 10 min. An aliquot was saved as input, and 50 ml of 50% (v/ v) of 1:1 protein A:G Sepharose beads, which had been washed twice with 150 mM NaCl, 20 mM Tris, pH 7.5, was added to preclear each sample. One microgram of rabbit anti-mSin3A antiserum (K20, Santa Cruz Biotech., Santa Cruz, CA, USA) or rabbit IgG was added to 300 ml of each sample, which was then rocked at 41C for 3 h. For specific inhibition, 1 mg of mSin3A peptide was added at the same time as antiserum. Fifty microliters of 50% protein A:G beads was then added for 1 h. The beads were then washed three times with lysis buffer without peptide protease inhibitors and eluted using 1 Â Laemmli sample buffer. Samples were then subjected to Western blotting using GAL4 Ab RK5C1 (Santa Cruz).
